ImmunityBio Inc

IBRXNASDAQ · USD
8.22USD-0.09 (-1.09%)
1210

ImmunityBio Inc (IBRX) Unusual Options Activity Today

IBRX options volume power reached 19x on the previous trading day. The highest reading was on the $14.5 PUT expiring 2026-10-23.

Read more

Checking IBRX unusual options activity helps you spot when traders are making outsized bets on ImmunityBio Inc before the broader market catches on. ImmunityBio Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor IBRX unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching IBRX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking IBRX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and IBRX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co.

Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.

Catalysts rarely arrive without a footprint, and IBRX unusual options activity is often where that footprint shows up first. Our scanner tracks ImmunityBio Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at IBRX unusual options volume on the call side or chasing put sweeps, ImmunityBio Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-30
Calls
8.500.250.450.3589%8312367.48%
3.504.206.705.45741%2922.22%
9.50—0.100.1092%4034911.46%
9.000.100.450.28110%4053,79910.66%
7.00—3.403.40629%1119.09%
Puts
8.500.150.750.4572%311,0353.00%
7.500.050.250.1597%2752.67%
9.000.701.200.95108%66120.98%
7.00—0.100.10115%11160.86%
10.001.502.301.90150%12710.37%

As of October 22, 2026

Spot unusual options activity before it moves

Track IBRX options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial